“We want to be disciplined financially,” CEO Stéphane Bancel, told Barron’s. Moderna says it has 10 products it hopes to launch over the next few years, including a flu vaccine, a ...

Moderna stock reversed higher Friday after Chief Executive Stephane Bancel deflected concerns over Robert F. Kennedy Jr. On ...

Over the last few years, with fears increased in the healthcare industry that its top executives could be targets of violence ...

The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of ...

Moderna's plans include a $1.1 billion reduction in R&D expenses by 2027 to a range of $3.6 billion to $3.8 billion. Rather than spending to explore new products, the company will shift its focus ...

The CEO of Moderna Inc. MRNA just purchased $5 million of stock in the open market. This is very significant since most of the insider trades have been sales for the past year. On March 4 ...

Kate Cronin, who took the marketing reins at Moderna in 2021 as it was skyrocketing to global renown for its COVID-19 vaccine, is stepping down from her post. Cronin joined Moderna in the summer ...

The Moderna CEO’s observation that existing vaccines will be less effective at tackling Omicron than earlier strains of Covid-19 rattled investors sufficiently to spark another global lurch ...

Moderna said Monday its COVID-19 vaccine is proving highly effective in a major trial, a second ray of hope in the global race for a shot to tame a resurgent virus that is now killing more than ...